A structure-activity relationship (SAR) study on 5-substituted oxazolidinones as an antibacterial agent is described. The oxazolidinones, of which 5-acetylaminomethyl moiety was converted into other functions, were prepared and evaluated for antibacterial activity. Elongation of the methylene chain (8) and conversion of the acetamido moiety into guanidino moiety (12) decreased the antibacterial activity. The replacement of carbonyl oxygen (‫؍‬O) by thiocarbonyl sulfur (‫؍‬S) enhanced in vitro antibacterial activity. Especially, compound 16, which had the 5-thiourea group, showed 4-8 stronger in vitro activity than linezolid. Our SAR study revealed that the antibacterial activity was greatly affected by the conversion of 5-substituent.
Several antibiotics have been widely prescribed and found to be greatly effective on various infectious disorders in recent years. The emergence of multi-drug-resistant grampositive bacteria, however, has become a significant problem. In particular, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are becoming imminent pathogens in clinical.
The oxazolidinones, exemplified by Dup-721 (1), 1) are an exciting new class of synthetic antibacterial agents and are reported to be effective against staphylococci, streptococci and enterococci.
2) Dup-721 has been found to effectively inhibit the protein synthesis in the initial stage.
3) Because of their unique mode of action, the oxazolidinones are thought to exhibit antibacterial activity without evidence of cross-resistance to any known antibiotics. However, Dupont's group was forced to discontinue the development of Dup-721 due to its severe toxicity. Pharmacia group then started a program to ameliorate the properties of Dup-721 and were successful in discovering PNU-100480 (2) 4) and linezolid (3) . 5) Linezolid is effective against numerous serious Gram-positive human pathogens caused by MRSA and VRE without severe toxicity. It has been shown to selectively bind to the 50S ribosomal subunit and to inhibit bacterial translation at the initial phase of protein synthesis. 6) Concerning the 5-substituent on the oxazolidinone ring, Dupont's group reported that the 5-hydroxymethyl or the 5-halogenomethyl group had weak antibacterial activities against gram-positive bacterial strains. 7) Furthermore, Gregory et al. 1) concluded that the acetylaminomethyl moiety was the best substituent at the 5-position on oxazolidinone, in consequence of their SAR study. But their effort was mainly limited to carbonyl functionalities. So we set about to convert the 5-substituent on the oxazolidinone into other functionalities such as thiocarbonyl groups, in order to determine the effect of the 5-substituent on antibacterial activity and to find a promising oxazolidinone antibacterial agent with excellent antibacterial activities against MRSA and VRE.
The introduction of thiocarbonyl functionalities, however, was reported by Bayer and Pharmacia groups simultaneously.
8) The two groups revealed that some 5-thiocarbonylfunctionalized oxazolidinones exhibited excellent activities at the same time that we synthesized a series of oxazolidinones with these functionalities. In this paper, we describe our extensive SAR study on various 5-substituents of oxazolidinone for antibacterial activity.
Chemistry Elongated compound 8 was synthesized as shown in Chart 2. Conversion of compound 4 to oxazolidinone 6 was accomplished by use of n-BuLi and (S)-3, 4-epoxybutenyl propionate (5). The alcohol 6 was reacted with methanesulfonyl chloride, followed by a treatment of sodium azide to yield compound 7. Hydrogenation of the azide 7 and following acetylation gave the desired compound 8.
5-Guanidine 12 and 5-thiocarbonyl compounds (13-21) were prepared as shown in Chart 3. The guanidine 12 was synthesized from 10 4) with 1H-pyrazole-1-carboxamidine. Thioamide derivatives (13) (14) (15) were efficiently obtained by treatment of the reference compounds (2, 22, 23) with Lawesson's reagent. Thiourea derivatives (16, 19) were obtained from isothiocyanate 11, which was easily derived from key intermediate 10 with carbon disulfide and ethyl chloroformate. The other thiourea derivatives (17, 18) were synthesized by treatment of compound 10 with various alkylisothiocyanate reagents. Thiosemicarbazide derivative (20) was syn-thesized from 10 with 4-methyl-4-phenyl-3-thiosemicarbazide. Regarding N,NЈ-dimethylthiourea derivative (21), the substitution of methanesulfonyl group (9) with methylamine followed by the reaction with methylisothiocyanate reagent gave the desired compound. The physicochemical data of these compounds are listed in the experimental section.
Results and Discussion
All of the oxazolidinone derivatives were tested for antibacterial activity against both standard (Staphylococcus aureus SMITH) and clinically isolated strains [S. aureus HPC1360 (MRSA), S. aureus HPC428 (MRSA), Enterococcus faecium HPC1322 and E. casseliflavus HPC1310 (VRE)]. Their minimum inhibitory concentrations (MICs mg/ml) are shown in Table 1 . Linezolid (3) and vancomycin were used as reference compounds.
The elongated compound 8 showed no antibacterial activity. This result suggested that the length of methylene (n) at 5-position would greatly influence the activity and that suitable length for the activity would be nϭ1. We next replaced the carbonyl oxygen (ϭO) by imino nitrogen (ϭNH) or thiocarbonyl sulfur (ϭS) and investigated their influence on the antibacterial activity. The guanidine compound 12 was inactive while the corresponding urea compound 24 showed moderate activity. The guanidino moiety exists in equilibrium with three conjugated bases since proton dissociation can occur from each of the three nitrogen atoms; it is normally considered to exist as a charged monocationic species under any physiological conditions that might be envisaged. We assumed that these characteristics of guanidino moiety might reduce the activity. On the other hand, the replacement of carbonyl oxygen (ϭO) by thiocarbonyl sulfur (ϭS) (13 vs. 22, 15 vs. 23, 16 vs. 24) enhanced antibacterial activity. Especially, the activity of thiourea derivative 16 was 2-4 times stronger than that of the corresponding urea compound 24. Moreover, the activity of compound 16 was 4-8 times stronger than that of linezolid (3) . The introduction of methyl (17), ethyl (18) and dimethyl (19) groups at the terminal ni-trogen atom, however, led to remarkably decreased antibacterial activities. Partition coefficient (log P), which is well used as an index of lipophilicity, is one of the important physicochemical parameters. We were interested in their lipophilicities since the introduction of alkyl groups induced the increase of lipophilicity. However, thiosemicarbazide compound 20 also decreased antibacterial activity in spite of its hydrophilicity (Ϫ0.14). Additionally, compound 20 had antibacterial activity similar to compounds 17 and 18, though they had quite different calculated log P values. Thus, the variety of antibacterial activity by introduction of the substituent at the terminal nitrogen atom seems to be caused by other factors, such as bulkiness of the substituent, rather than by the variety of lipophilicity.
We next investigated the effect of hydrogen atom (R 1 ) at the proximal nitrogen atom. Methylation at the proximal nitrogen atom, as demonstrated for compound 21, was inactive. Therefore, the hydrogen atom at this position is essential for antibacterial activity in 5-thiocarbonyl oxazolidinone. Denis and Seneci 11) reported that the oxygen atom at 1-position on oxazolidinone ring was indispensable for the appearance of antibacterial activity. And some reports referred to the presence of an internal hydrogen bond as an active conformation in [2-(4-piperidinyl) ethyl]thiourea or phenethylthiazolethiourea compounds. 12) We therefore assumed that pseudo intramolecular hydrogen bonding between NH moiety at the 5-position and oxygen atom on the oxazolidinone ring could be formed and be considered to act as an active conformation. However, the existence of intramolecular hydrogen bonding was not observed in our 1 H-NMR studies by comparison with corresponding pyrrolidone derivatives that could not form the internal hydrogen bond with NH moiety at 5-position. The NH moiety is probably essential as the binding site in 5-thiocarbonyl oxazolidinones.
In conclusion, we synthesized some oxazolidinones in order to investigate the effect of the 5-substituent for antibacterial activity. It was proved that the antibacterial activity was greatly affected by conversion of the 5-substituent, as a consequence of our effort. Among them, 5-thiocarbonyl groups, especially the 5-thiourea group, would take the place of 5-acetamide group for the activity. Compound 16, which has 5-thiourea moiety, was found to be one of the most potent candidates for the activity.
Experimental
Melting points were measured with a Yanagimoto melting point apparatus and are uncorrected. Elemental analyses were measured with a Yanagimoto MT-5 elemental analysis apparatus, and were within Ϯ0.4% of calculated values. 1 H-NMR spectra were measured with a JEOL A-500 (500 MHz) or JEOL JNM-LA300 (300 MHz) spectrometer using tetramethylsilane as an internal standard. Specific optical rotations were measured on a JASCO DIP-370 polarimeter. Column chromatography was carried out with silica gel [Kieselgel 60(Merck) ]. TLC was conducted on 0.25 mm pre-coated silica gel plates (60F 254 , Merck). All extracted solvents were dried over Na 2 SO 4 and the solvent was evaporated in vacuo.
(S)-3, 4-Epoxybutenyl Propionate (5) A suspension of (S)-(Ϫ)-4-iodo-1, 2-epoxybutane 13) (1.00 g, 5.05 mmol), propionic acid (0.37 ml, 5.05 mmol) and K 2 CO 3 (0.90 g, 6.51 mmol) in methylethylketone (14 ml) was refluxed at 18 h. The mixture was diluted with water and extracted with AcOEt. The extract was washed with brine, dried and concentrated. The residue was purified by column chromatography [SiO 2 , n-Hexane-AcOEt under N 2 at Ϫ70°C, n-BuLi (37. (
S)-5-Azidoethyl-3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]oxazolidine-2-one (7)
To a mixture of 6 (3.50 g, 10.7 mmol) and Et 3 N (3.40 ml, 24.2 mmol) in CH 2 Cl 2 (70 ml), methanesulfonyl chloride (1.00 ml, 13.1 mmol) was added under ice cooling, followed by stirring at room temperature for 1 h. The reaction mixture was washed with water and brine, dried and concentrated to give methanesulfonate. A suspension of the methanesulfonate and sodium azide (2.65 g, 40.7 mmol) in N,N-dimethylformamide (DMF) (93 ml) was heated at 65°C for 6 h. After cooling, the reaction mixture was poured into water and extracted with AcOEt. The extract was washed with brine, dried and concentrated to afford 7 (4.69 g, 100%) as pale brown crystals. Recrystallization from MeOH gave pale brown crystals. mp: 101. (
S)-[[3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl] ethyl]acetamide (8)
A mixture of 7 (4.09 g, 11.6 mmol) and triphenylphosphine (3.36 g, 12.8 mmol) and H 2 O (4 ml, 116 mmol) in THF (60 ml) was heated at 40°C for 17 h. After cooling, the reaction mixture was diluted with dilute hydrochloric acid and extracted with AcOEt. The aqueous layer was made alkaline with aqueous NaOH and extracted with AcOEt. The extract was washed with water, dried and concentrated to afford pale yellow crystals.
To a solution of the above crystals in pyridine (10 ml), acetic anhydride (5.50 ml, 58.2 mmol) was added under ice cooling, followed by stirring at room temperature for 1 h. The reaction mixture was evaporated, and then the residue was diluted with dilute hydrochloric acid, and extracted with AcOEt. The extract was washed with brine, dried and concentrated. The residue was washed with AcOEt to afford 8 as pale yellow crystals. The physicochemical data are listed in Tables 2 and 3 .
(
R)-[[3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl] methyl]isothiocyanate (11)
A mixture of 10 4) (5.00 g, 16.1 mmol), carbon disulfide (1.00 ml, 16.1 mmol) and Et 3 N (2.30 ml, 16.1 mmol) in THF (50 ml) was stirred at room temperature for 5 h. Then ethyl chloroformate (1.53 ml, 16.1 mmol) was added to the mixture and stirred at the same temperature for 1 h. The mixture was quenched with water and extracted with AcOEt. The extract was washed with brine, dried and concentrated. The residue was purified by column chromatography [SiO 2 , CH 2 Cl 2 -MeOH (50 : 1)] to give 11 (3. , N,N-diisopropylethylamine (0.25 ml, 1.45 mmol) and 1H-pyrazole-1-carboxamidine hydrochloride (0.21 g, 1.45 mmol) in DMF (3 ml) was heated at 50°C for 1.5 h. After cooling, the reaction mixture was diluted with CH 2 Cl 2 . The precipitates were collected by filtration and washed with water to afford 12 as colorless crystals. The physicochemical data are listed in Tables 2 and  3 .
S)-N-[[3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]thioacetamide (14)
A mixture of 2 4) (1.58 g, 4.47 mmol) and Lawesson's reagent (1.80 g, 4.47 mmol) in toluene (20 ml) was heated at 90°C for 7 h. After the cooling, the reaction mixture was diluted with water, and extracted with AcOEt. The extract was washed with brine, dried and concentrated. The residue was purified by column chromatography [SiO 2 , AcOEt-n-Heptane (1 : 1)] to afford 14 as colorless crystals. The physicochemical data are listed in Tables 2 and 3 .
Compounds 13 and 15 were prepared in a similar manner, and their physicochemical data are also listed in Tables 2 and 3 .
S)-N-[[3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]thiourea (16)
A mixture of 11 (0.50 g, 1.42 mmol) and 16% ammonia in methanol solution (10 ml) in MeOH (10 ml) was stirred at room temperature for 2 h. The precipitates were collected by filtration and washed with MeOH to afford 16 as colorless crystals. The physicochemical data are listed in Tables 2 and 3 .
Compound 19 was prepared in a similar manner. The physicochemical data are also listed in Tables 2 and 3 .
S)-N-Methyl-N-[[3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]thiourea (17)
A mixture of 10 (9.84 g, 16.0 mmol), Et 3 N (5.00 ml, 35.9 mmol) and methyl isothiocyanate (2.30 ml, 32.0 mmol) in CH 2 Cl 2 (100 ml) was stirred at room temperature for 18 h. The mixture was washed with water, dried and concentrated. The residue was purified by column chromatography [SiO 2 , CH 2 Cl 2 -MeOH (30 : 1)] to give 17 as colorless crystals. The physicochemical data are listed in Tables 2 and 3 .
Compound 18 was prepared in a similar manner. The physicochemical data are listed in Tables 2 and 3 9 4) (1.00 g, 2.67 mmol), MeOH (10 ml) and 40% methylamine in methanol solution (6ml) was refluxed for 72 h. The mixture was concentrated, and then the residue was treated with Et 3 N (0.80 ml, 5.63 mmol) and methyl isothiocyanate (0.70 ml, 7.47 mmol) in CH 2 Cl 2 (16 ml) at room temperature and stirred for 2.5 h.
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Vol. 49, No. 4 The reaction mixture was washed with water, dried and concentrated to afford 21 as pale yellow crystals. The physicochemical data are listed in Ta 21 mmol) and ethyl formate (3.00 ml, 38.5 mmol) in EtOH (10 ml) was refluxed for 17 h. After cooling, the reaction mixture was concentrated. The residue was washed with EtOH to afford 22 as colorless crystals. The physicochemical data of compound 22 are listed in Tables 2 and 3 and Et 3 N (0.49 ml, 3.53 mmol) in THF (10 ml), propionyl chloride (0.31 ml, 3.53 mmol) was added under ice cooling, followed by stirring at the same temperature for 5 h. Then the reaction mixture was washed with water and extracted with AcOEt. The extract was dried and concentrated to afford 23 as pale brown crystals. The physicochemical data are listed in Tables 2 and  3 .
S)-N-[[3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl] methyl]urea (24)
A mixture of 10 (0.30 g, 0.963 mmol) and sodium cyanate (0.22 g, 2.89 mmol) in acetic acid-water 1 : 1 (2.4 ml) was stirred at room temperature for 4 h. The reaction mixture was evaporated, and the residue was washed with water to afford 24 as colorless crystals. The physicochemical data of compound 24 are listed in Tables 2 and 3 .
In Vitro Studies These studies were conducted according to the method of the Japan Society of Chemotherapy.
14) The minimum inhibitory concentrations (MICs, mg/ml) were determined by an agar dilution method with Muller-Hinton agar (MHA, Difco Laboratories, Detroit, Mich). Bacterial suspensions for inocula were prepared by diluting overnight cultures of organisms to give a final concentration of 10 6 CFU/ml, and one loopful (5 ml) of an inoculum, corresponding to about 5ϫ10 3 CFU per spot was inoculated on drug-containing agar plates. The plates were incubated for 18-24 h at 37°C
. The MIC was defined as the lowest drug concentration that prevented visible growth of bacteria.
